Page last updated: 2024-08-21

3-hydroxyflavone and Laryngeal Neoplasms

3-hydroxyflavone has been researched along with Laryngeal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jia, SS; Zhang, XJ	1

Other Studies

1 other study(ies) available for 3-hydroxyflavone and Laryngeal Neoplasms

Article	Year
Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 83 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Flavonols; Humans; Laryngeal Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; NF-kappa B; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Up-Regulation; Xenograft Model Antitumor Assays	2016

Article

Year

Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 83

Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Flavonols; Humans; Laryngeal Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; NF-kappa B; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Up-Regulation; Xenograft Model Antitumor Assays

2016